Beta Bionics (BBNX) Short-term Investments (2023 - 2026)

Beta Bionics has disclosed Short-term Investments across 4 years of filings, most recently posting $100000.0 for Q1 2026.

• Short-term Investments for Q1 2026 came in at $100000.0, down 99.95% year-over-year; the trailing twelve-month figure through Mar 2026 was $100000.0 (down 99.95% YoY), and the FY2025 annual result was $187.5 million, up 156.41% from the prior year.
• Short-term Investments came in at $100000.0 for Q1 2026 at Beta Bionics, down from $187.5 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $214.6 million in Q2 2025 to a low of $100000.0 in Q1 2026.
• The 4-year median for Short-term Investments is $187.5 million (2025), against an average of $132.1 million.
• Across the five-year window, Short-term Investments soared 156.41% in 2025 and sank 99.95% in 2026, its largest moves.
• Beta Bionics' Short-term Investments stood at $70.2 million in 2023, then increased by 4.22% to $73.1 million in 2024, then jumped by 156.41% to $187.5 million in 2025, then plunged by 99.95% to $100000.0 in 2026.
• The last three Short-term Investments figures came in at $100000.0 (Q1 2026), $187.5 million (Q4 2025), and $190.2 million (Q3 2025), per Business Quant data.